Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Cost-analysis
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(2)
+
-
Availability
Open access
(2)
+
-
Metadata Only
(1)
+
-
Creation Date
2019
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(3)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(3)
+
-
Topic
Cost-analysis
(3)
+
-
DPYD
(2)
+
-
Dihydropyrimidine dehydrogenase
(2)
+
-
Fluoropyrimidines
(2)
+
-
Genotyping
(2)
+
-
Pharmacogenetics
(2)
+
-
Toxicity
(2)
+
-
Show more
Author
Baars, A.
(2)
+
-
Beijnen, J.H.
(2)
+
-
Cats, A.
(2)
+
-
Creemers, G.J.
(2)
+
-
Droogendijk, H.J.
(2)
+
-
Frederix, G.W.J.
(2)
+
-
Gelderblom, H.
(2)
+
-
Guchelaar, H.J.
(2)
+
-
Hamberg, P.
(2)
+
-
Henricks, L.M.
(2)
+
-
Imholz, A.L.T.
(2)
+
-
Jansen, R.L.H.
(2)
+
-
Jeurissen, F.J.F.
(2)
+
-
Kienhuis, E.
(2)
+
-
Koopman, M.
(2)
+
-
Kuilenburg, A.B.P. van
(2)
+
-
Lunenburg, C.A.T.C.
(2)
+
-
Man, F.M. de
(2)
+
-
Mandigers, C.M.P.W.
(2)
+
-
Mathijssen, R.H.J.
(2)
+
-
Meulendijks, D.
(2)
+
-
Nieboer, P.
(2)
+
-
Poel, M.H.W. van de
(2)
+
-
Portielje, J.E.A.
(2)
+
-
Rosing, H.
(2)
+
-
Schaik, R.H.N. van
(2)
+
-
Schellens, J.H.M.
(2)
+
-
Swen, J.J.
(2)
+
-
Tije, A.J. ten
(2)
+
-
Werkhoven, E. van
(2)
+
-
Show more
Language
en
(3)
+
-
Search results
(1 - 3 of 3)
show grid
show list
save search
Risk stratification of outpatient management in acute venous thromboembolism
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy